| (USD) | Dec 2024 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RNAZ returned -72.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -58.0% |
| 1 year | -72.0% |
| 5 years | -100.0% |
| All-time high | $2,247,168.00 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RNAZ would be worth today ›No. TransCode Therapeutics, Inc. has not paid a dividend in the past 12 months.
TransCode Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol RNAZ.
TransCode Therapeutics, Inc. is part of the Healthcare sector.
TransCode Therapeutics, Inc. has a market cap of 3.04M USD, based on the latest quote.
